Suono Bio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $500K

  • Investors
  • 12

Suono Bio General Information

Description

Developer of therapeutic products designed for the treatment of inflammatory-mediated diseases. The company's platform allows ultra-rapid delivery of therapies and macromolecules across tissues including biologics and nucleic acids that are delivered directly into the gastrointestinal tissues with small molecules, proteins, vaccines, and nucleic acids, enabling patients to recover from gastrointestinal diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 200 Foxborough Boulevard
  • Suite 100
  • Foxborough, MA 02035
  • United States
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 200 Foxborough Boulevard
  • Suite 100
  • Foxborough, MA 02035
  • United States

Suono Bio Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Suono Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 28-Aug-2023 $500K Completed Clinical Trials - General
6. Later Stage VC (Series A) 07-Jul-2021 Completed Pre-Clinical Trials
5. Grant 01-May-2019 Completed Pre-Clinical Trials
4. Early Stage VC (Series A) 19-Sep-2017 Completed Pre-Clinical Trials
3. Accelerator/Incubator 13-Oct-2016 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2016 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view Suono Bio’s complete valuation and funding history, request access »

Suono Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A NV
To view Suono Bio’s complete cap table history, request access »

Suono Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic products designed for the treatment of inflammatory-mediated diseases. The company's platform a
Drug Delivery
Foxborough, MA
13 As of 2023

Florham Park, NJ
 

Geneva, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Suono Bio Competitors (23)

One of Suono Bio’s 23 competitors is Phathom Pharmaceuticals, a Formerly VC-backed company based in Florham Park, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phathom Pharmaceuticals Formerly VC-backed Florham Park, NJ
Light Chain Bioscience Private Equity-Backed Geneva, Switzerland
Voyager Therapeutics Corporation Lexington, MA
Jnana Therapeutics Formerly VC-backed Boston, MA
NexImmune Formerly VC-backed Gaithersburg, MD
You’re viewing 5 of 23 competitors. Get the full list »

Suono Bio Patents

Suono Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4326383-A1 System containing ingestible ultrasound device for delivery of therapeutic agents Pending 19-Apr-2021
US-20240198066-A1 System containing ingestible ultrasound device for delivery of therapeutic agents Pending 19-Apr-2021
CA-3216870-A1 System containing ingestible ultrasound device for delivery of therapeutic agents Pending 19-Apr-2021
EP-4210586-A1 Ultrasound flexural waveguide Pending 14-Sep-2020
US-20230364404-A1 Ultrasound flexural waveguide Pending 14-Sep-2020 A61M37/0092
To view Suono Bio’s complete patent history, request access »

Suono Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Suono Bio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axil Capital Partners Venture Capital Minority
Gutbrain Ventures Venture Capital Minority
Mizuho Securities Investment Bank Minority
PBJ Capital Venture Capital Minority
Taiwania Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Suono Bio FAQs

  • When was Suono Bio founded?

    Suono Bio was founded in 2015.

  • Where is Suono Bio headquartered?

    Suono Bio is headquartered in Foxborough, MA.

  • What is the size of Suono Bio?

    Suono Bio has 13 total employees.

  • What industry is Suono Bio in?

    Suono Bio’s primary industry is Drug Delivery.

  • Is Suono Bio a private or public company?

    Suono Bio is a Private company.

  • What is Suono Bio’s current revenue?

    The current revenue for Suono Bio is .

  • How much funding has Suono Bio raised over time?

    Suono Bio has raised $14M.

  • Who are Suono Bio’s investors?

    Axil Capital Partners, Gutbrain Ventures, Mizuho Securities, PBJ Capital, and Taiwania Capital are 5 of 12 investors who have invested in Suono Bio.

  • Who are Suono Bio’s competitors?

    Phathom Pharmaceuticals, Light Chain Bioscience, Voyager Therapeutics, Jnana Therapeutics, and NexImmune are some of the 23 competitors of Suono Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »